Food for thought: Understanding the multifaceted nature of orexins

Endocrinology

Volumn 154, Issue 11, 2013, Pages 3990-3999

  Sellayah, Dyan ^a   Sikder, Devanjan ^a  

^a BURNHAM INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OREXIN;

BROWN ADIPOSE TISSUE; DIET; ENERGY EXPENDITURE; FEEDING; HIBERNATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SLEEP WAKING CYCLE; THERMOGENESIS;

ADIPOSE TISSUE, BROWN; AROUSAL; EATING; HUMANS; HYPOTHALAMUS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDES; SLEEP;

EID: 84886580431     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1488     Document Type: Review

References (144)

1. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92: 573-585.
2. Edwards CM, Abusnana S, Sunter D, Murphy KG, Ghatei MA, Bloom SR. The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin. J Endocrinol. 1999;160:R7-R12.
3. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999; 98: 437-451.
4. Lee MG, Hassani OK, Jones BE. Discharge of identified orexin/ hypocretin neurons across the sleep-waking cycle. J Neurosci. 2005; 25: 6716-6720.
5. Plazzi G, Moghadam KK, Maggi LS, et al. Autonomic disturbances in narcolepsy. Sleep Med Rev. 2011;15: 187-196.
6. López M, Tena-Sempere M, Diéguez C. Cross-talk between orexins (hypocretins) and the neuroendocrine axes (hypothalamic-pituitary axes). Front Neuroendocrinol. 2010;31: 113-127.
7. Lopez M, Nogueiras R, Tena-Sempere M, Dieguez C. Orexins (hypocretins) actions on the GHRH/somatostatin-GH axis. Acta Physiol (Oxf). 2010;198: 325-334.
8. López M, Señarís R, Gallego R, et al. Orexin receptors are expressed in the adrenal medulla of the rat. Endocrinology. 1999;140: 5991-5994.
9. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med. 2000;6: 991-997.
10. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron. 2000;27: 469-474.
11. Beuckmann CT, Sinton CM, Williams SC, et al. Expression of a poly-glutamine-ataxin-3 transgene in orexin neurons induces narcolepsy- cataplexy in the rat. J Neurosci. 2004;24: 4469-4477.
12. Kantor S, Mochizuki T, Janisiewicz AM, Clark E, Nishino S, Scammell TE. Orexin neurons are necessary for the circadian control of REM sleep. Sleep. 2009;32: 1127-1134.
13. Kirsz K, Szczesna M, Molik E, Misztal T, Wojtowicz AK, Zieba DA. Seasonal changes in the interactions among leptin, ghrelin, and orexin in sheep. J Anim Sci. 2012;90: 2524-2531.
14. Khorooshi RM, Klingenspor M. Neuronal distribution of melaninconcentrating hormone, cocaine- and amphetamine-regulated transcript and orexin B in the brain of the Djungarian hamster (Phodopus sungorus). J Chem Neuroanat. 2005;29: 137-148.
15. Janssen R. Thermal influences on nervous system function. Neurosci Biobehav Rev. 1992;16: 399-413.
16. Boutrel B, Kenny PJ, Specio SE, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA. 2005;102: 19168-19173.
17. Kuwaki T. Orexin links emotional stress to autonomic functions. Auton Neurosci. 2011;161: 20-27.
18. Cortese S, Konofal E, Lecendreux M. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role? Med Hypotheses. 2008;71: 770-775.
19. Aston-Jones G. Brain structures and receptors involved in alertness. Sleep Med. 2005;6(suppl 1):S3-S7.
20. Sellayah D, Bharaj P, Sikder D. Orexin is required for brown adipose tissue development, differentiation, and function. Cell Metab. 2011; 14: 478-490.
21. Sellayah D, Sikder D. Orexin receptor-1 mediates brown fat developmental differentiation. Adipocyte. 2012;1: 58-63.
22. Madden CJ, Tupone D, Morrison SF. Orexin modulates brown adipose tissue thermogenesis. Biomol Concepts. 2012;3: 381-386.
23. Morrison SF, Madden CJ, Tupone D. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. Adipocyte. 2012;1: 116-120.
24. Tupone D, Madden CJ, Cano G, Morrison SF. An orexinergic projection from perifornical hypothalamus to raphe pallidus increases rat brown adipose tissue thermogenesis. J Neurosci. 2011;31: 15944-15955.
25. Cannon B, Nedergaard J. Brown adipose tissue: function and physiological significance. Physiol Rev. 2004;84: 277-359.
26. Nedergaard J, Cannon B. Preferential utilization of brown adipose tissue lipids during arousal from hibernation in hamsters. Am J Physiol. 1984;247:R506-R512.
27. Ootsuka Y, Kulasekara K, de Menezes RC, Blessing WW. SR59230A, aβ-3 adrenoceptor antagonist, inhibits ultradianbrown adipose tissue thermogenesis and interrupts associated episodic brain and body heating. Am J Physiol Regul Integr Comp Physiol. 2011;301:R987-R994.
28. Demas GE, Bowers RR, Bartness TJ, Gettys TW. Photoperiodic regulation of gene expression in brown and white adipose tissue of Siberian hamsters (Phodopus sungorus). Am J Physiol Regul Integr Comp Physiol. 2002;282:R114-R121.
29. Himms-Hagen J. Role of brown adipose tissue thermogenesis in control of thermoregulatory feeding in rats: a new hypothesis that links thermostatic and glucostatic hypotheses for control of food intake. Proc Soc Exp Biol Med. 1995;208: 159-169.
30. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus- specific peptides with neuroexcitatory activity. Proc Natl Acad Sci USA. 1998;95: 322-327.
31. Haynes AC, Jackson B, Chapman H, et al. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regul Pept. 2000;96: 45-51.
32. Willie JT, Chemelli RM, Sinton CM, Yanagisawa M. To eat or to sleep? Orexin in the regulation of feeding and wakefulness. Annu Rev Neurosci. 2001;24: 429-458.
33. Gunapala KM, Gallardo CM, Hsu CT, Steele AD. Single gene deletions of orexin, leptin, neuropeptide Y, and ghrelin do not appreciably alter food anticipatory activity in mice. PLoS One. 2011;6: e18377.
34. Matsuo E, Mochizuki A, Nakayama K, et al. Decreased intake of sucrose solutions in orexin knockout mice. J Mol Neurosci. 2011; 43: 217-224.
35. Clark EL, Baumann CR, Cano G, Scammell TE, Mochizuki T. Feeding- elicited cataplexy in orexin knockout mice. Neuroscience. 2009; 161: 970-977.
36. YamanakaA,BeuckmannCT,Willie JT, et al. Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron. 2003;38: 701-713.
37. Burdakov D, Gerasimenko O, Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J Neurosci. 2005;25: 2429-2433.
38. López M, Seoane L, García MC, et al. Leptin regulation of preproorexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun. 2000;269: 41-45.
39. SchwartzMW,WoodsSC, PorteDJr, Seeley RJ, BaskinDG.Central nervous system control of food intake. Nature. 2000;404: 661-671.
40. Rauch M, Riediger T, Schmid HA, Simon E. Orexin A activates leptin-responsive neurons in the arcuate nucleus. Pflugers Arch. 2000;440: 699-703.
41. KohnoD,GaoHZ,MuroyaS, Kikuyama S,YadaT. Ghrelin directly interacts with neuropeptide-Y-containing neurons in the rat arcuate nucleus: Ca2+ signaling via protein kinase A and N-type channeldependent mechanisms and cross-talk with leptin and orexin. Diabetes. 2003;52: 948-956.
42. López M, Seoane LM, García Mdel C, Diéguez C, Señarís R. Neuropeptide Y, but not agouti-related peptide or melanin-concentrating hormone, is a target peptide for orexin-A feeding actions in the rat hypothalamus. Neuroendocrinology. 2002;75: 34-44.
43. Elias CF, Saper CB, Maratos-Flier E, et al. Chemically defined projections linking the mediobasal hypothalamus and the lateral hypothalamic area. J Comp Neurol. 1998;402: 442-459.
44. Stanley BG, Thomas WJ. Feeding responses to perifornical hypothalamic injection of neuropeptide Y in relation to circadian rhythms of eating behavior. Peptides. 1993;14: 475-481.
45. Kotz CM, Teske JA, Levine JA, Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul Pept. 2002;104: 27-32.
46. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8: 171-181.
47. Thorpe AJ, KotzCM.OrexinAin the nucleus accumbens stimulates feeding and locomotor activity. Brain Res. 2005;1050: 156-162.
48. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol. 2002;59: 1553-1562.
49. Saper CB. The neurobiology of sleep. Continuum (Minneap Minn). 2013;19: 19-31.
50. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999;98: 365-376.
51. Savvidou A, Knudsen S, Olsson-Engman M, Gammeltoft S, Jennum P, Palm L. Hypocretin deficiency develops during onset of human narcolepsy with cataplexy. Sleep. 2013;36: 147-148.
52. Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev. 2009;61: 162-176.
53. Hara J, Beuckmann CT, Nambu T, et al. Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity. Neuron. 2001;30: 345-354.
54. Crocker A, España RA, Papadopoulou M, et al. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy. Neurology. 2005; 65: 1184-1188.
55. Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun. 2013; 43: 26-31.
56. Date Y, Ueta Y, Yamashita H, et al. Orexins, orexigenic hypothalamic peptides, interact with autonomic, neuroendocrine and neuroregulatory systems. Proc Natl Acad Sci USA. 1999;96: 748-753.
57. NambuT, Sakurai T, Mizukami K, Hosoya Y, YanagisawaM,Goto K. Distribution of orexin neurons in the adult rat brain. Brain Res. 1999;827: 243-260.
58. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18: 9996-10015.
59. Yamanaka A, Tsujino N, Funahashi H, et al. Orexins activate histaminergic neurons via the orexin 2 receptor. Biochem Biophys Res Commun. 2002;290: 1237-1245.
60. Horvath TL, Peyron C, Diano S, et al. Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system. J Comp Neurol. 1999;415: 145-159.
61. Liu RJ, van den Pol AN, Aghajanian GK. Hypocretins (orexins) regulate serotonin neurons in the dorsal raphe nucleus by excitatory direct and inhibitory indirect actions. J Neurosci. 2002;22: 9453-9464.
62. Takahashi K, Koyama Y, Kayama Y, Yamamoto M. Effects of orexin on the laterodorsal tegmental neurones. Psychiatry Clin Neurosci. 2002;56: 335-336.
63. Takakusaki K, Takahashi K, Saitoh K, et al. Orexinergic projections to the cat midbrain mediate alternation of emotional behavioural states from locomotion to cataplexy. J Physiol. 2005;568: 1003-1020.
64. Marston OJ, Williams RH, Canal MM, Samuels RE, Upton N, Piggins HD. Circadian and dark-pulse activation of orexin/hypocretin neurons. Mol Brain. 2008;1:19.
65. Deurveilher S, Semba K. Indirect projections from the suprachiasmatic nucleus to major arousal-promoting cell groups in rat: implications for the circadian control of behavioural state. Neuroscience. 2005;130: 165-183.
66. Stanley S, Wynne K, McGowan B, Bloom S. Hormonal regulation of food intake. Physiol Rev. 2005;85: 1131-1158.
67. Chabas D, Foulon C, Gonzalez J, et al. Eating disorder and metabolism in narcoleptic patients. Sleep. 2007;30: 1267-1273.
68. Challet E, Pevet P, Malan A. Effect of prolonged fasting and subsequent refeeding on free-running rhythms of temperature and locomotor activity in rats. Behav Brain Res. 1997;84: 275-284.
69. Itoh T, Murai S, Nagahama H, et al. Effects of 24-hr fasting on methamphetamine- and apomorphine-induced locomotor activities, and on monoamine metabolism in mouse corpus striatum and nucleus accumbens. Pharmacol Biochem Behav. 1990;35: 391-396.
70. Markwald RR, Melanson EL, Smith MR. Impact of insufficient sleep on total daily energy expenditure, food intake, and weight gain. Proc Natl Acad Sci USA. 2013;110: 5695-5700.
71. Schwartz JR, Roth T. Neurophysiology of sleep and wakefulness: basic science and clinical implications. Curr Neuropharmacol. 2008;6: 367-378.
72. Balbo M, Leproult R, Van Cauter E. Impact of sleep and its disturbances on hypothalamo-pituitary-adrenal axis activity. Int J Endocrinol. 2010;2010:759234.
73. Mieda M, Willie JT, Hara J, Sinton CM, Sakurai T, Yanagisawa M. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice. Proc Natl Acad Sci USA. 2004;101: 4649-4654.
74. Mieda M, Williams SC, Richardson JA, Tanaka K, Yanagisawa M. The dorsomedial hypothalamic nucleus as a putative food-entrainable circadian pacemaker. Proc Natl Acad Sci USA. 2006;103: 12150-12155.
75. Yoshida K, McCormack S, España RA, Crocker A, Scammell TE. Afferents to the orexin neurons of the rat brain. J Comp Neurol. 2006;494: 845-861.
76. Hara J, Yanagisawa M, Sakurai T. Difference in obesity phenotype between orexin-knockout mice and orexin neuron-deficient mice with same genetic background and environmental conditions. Neurosci Lett. 2005;380: 239-242.
77. Teske JA, Billington CJ, Kotz CM. Hypocretin/orexin and energy expenditure. Acta Physiol (Oxf). 2010;198: 303-312.
78. Cannon B, Nedergaard J. Metabolic consequences of the presence or absence of the thermogenic capacity of brown adipose tissue in mice (and probably in humans). Int J Obes (Lond). 2010;34(suppl 1): S7-S16.
79. Nedergaard J, Bengtsson T, Cannon B. Three years with adult human brown adipose tissue. AnnNYAcad Sci. 2010;1212:E20-E36.
80. Nedergaard J, Cannon B. The changed metabolic world with human brown adipose tissue: therapeutic visions. Cell Metab. 2010;11: 268-272.
81. Richard D, Picard F. Brown fat biology and thermogenesis. Front Biosci. 2011;16: 1233-1260.
82. Ravussin E, Kozak LP. Have we entered the brown adipose tissue renaissance? Obes Rev. 2009;10: 265-268.
83. Lowell BB, Spiegelman BM. Towards a molecular understanding of adaptive thermogenesis. Nature. 2000;404: 652-660.
84. Fromme T, Klingenspor M. Uncoupling protein 1 expression and high-fat diets. Am J Physiol Regul Integr Comp Physiol. 2011;300: R1-R8.
85. Rothwell NJ, Stock MJ. A role for brown adipose tissue in dietinduced thermogenesis. Nature. 1979;281: 31-35.
86. Feldmann HM, Golozoubova V, Cannon B, Nedergaard J. UCP1 ablation induces obesity and abolishes diet-induced thermogenesis in mice exempt from thermal stress by living at thermoneutrality. Cell Metab. 2009;9: 203-209.
87. Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360: 1518-1525.
88. Cypess AM, Lehman S, Williams G, et al. Identification and importance of brown adipose tissue in adult humans.NEngl J Med. 2009; 360: 1509-1517.
89. Lean ME, James WP, Jennings G, Trayhurn P. Brown adipose tissue uncoupling protein content in human infants, children and adults. Clin Sci (Lond). 1986;71: 291-297.
90. Stock MJ, Rothwell NJ. Factors influencing brown fat and the capacity for diet-induced thermogenesis. Int J Obes (Lond). 1985; 9(suppl 2):9-15.
91. Tseng YH, Kokkotou E, Schulz TJ, et al. New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature. 2008;454: 1000-1004.
92. Whittle AJ, Carobbio S, Martins L, et al. BMP8B increases brown adipose tissue thermogenesis through both central and peripheral actions. Cell. 2012;149: 871-885.
93. Tsukita S, Yamada T, Uno K, et al. Hepatic glucokinase modulates obesity predisposition by regulating BAT thermogenesis via neural signals. Cell Metab. 2012;16: 825-832.
94. Hata K, Nishimura R, Ikeda F, et al. Differential roles of Smad1 and p38 kinase in regulation of peroxisome proliferator-activating receptor γ during bone morphogenetic protein 2-induced adipogenesis. Mol Biol Cell. 2003;14: 545-555.
95. Huang H, Song TJ, Li X, et al. BMP signaling pathway is required for commitment of C3H10T1/2 pluripotent stem cells to the adipocyte lineage. Proc Natl Acad Sci USA. 2009;106: 12670-12675.
96. He Q, Huang C, Zhao L, et al. α-Naphthoflavone inhibits 3T3-L1 pre-adipocytes differentiation via modulating p38MAPK signaling. Int J Clin Exp Pathol. 2013;6: 168-178.
97. Maekawa T, Jin W, Ishii S. The role of ATF-2 family transcription factors in adipocyte differentiation: antiobesity effects of p38 inhibitors. Mol Cell Biol. 2010;30: 613-625.
98. Bost F, Aouadi M, Caron L, Binétruy B. The role of MAPKs in adipocyte differentiation and obesity. Biochimie. 2005;87: 51-56.
99. Lee JS, Park JH, Kwon IK, Lim JY. Retinoic acid inhibits BMP4- induced C3H10T1/2 stem cell commitment to adipocyte via downregulating Smad/p38MAPK signaling. Biochem Biophys Res Commun. 2011;409: 550-555.
100. Monda M, Viggiano A, Viggiano A, Viggiano E, De Luca V. Risperidone potentiates the sympathetic and hyperthermic reactions induced by orexin A in the rat. Physiol Res. 2006;55: 73-78.
101. Chaouloff F, Berton O, Mormède P. Serotonin and stress. Neuropsychopharmacology. 1999;21:28S-32S.
102. Zhang W, Sunanaga J, Takahashi Y, et al. Orexin neurons are indispensable for stress-induced thermogenesis in mice. J Physiol. 2010;588: 4117-4129.
103. Perez-Leighton CE, Billington CJ, KotzCM.Orexin modulation of adipose tissue [published online June 18, 2013]. Biochim Biophys Acta. doi:10.1016/j.bbadis.2013.06.007.
104. Teske JA, Mavanji V. Energy expenditure: role of orexin. Vitam Horm. 2012;89: 91-109.
105. Girault EM, Yi CX, Fliers E, Kalsbeek A. Orexins, feeding, and energy balance. Prog Brain Res. 2012;198: 47-64.
106. Archer ZA, Findlay PA, Rhind SM, Mercer JG, Adam CL. Orexin gene expression and regulation by photoperiod in the sheep hypothalamus. Regul Pept. 2002;104: 41-45.
107. Redlin U, Nuesslein B, Schmidt I. Circadian changes of brown adipose tissue thermogenesis in juvenile rats. Am J Physiol. 1992; 262:R504-R508.
108. Zvonic S, Ptitsyn AA, Conrad SA, et al. Characterization of peripheral circadian clocks in adipose tissues. Diabetes. 2006;55: 962-970.
109. Eley J, Himms-Hagen J. Brown adipose tissue of mice with GTGinduced obesity: altered circadian control. Am J Physiol. 1989; 256:E773-E779.
110. McElroy JF, Wade GN. Short photoperiod stimulates brown adipose tissue growth and thermogenesis but not norepinephrine turnover in Syrian hamsters. Physiol Behav. 1986;37: 307-311.
111. Abizaid A, Horvath TL. Brain circuits regulating energy homeostasis. Regul Pept. 2008;149: 3-10.
112. Leibowitz SF, Wortley KE. Hypothalamic control of energy balance: different peptides, different functions. Peptides. 2004;25: 473-504.
113. Huo L, Grill HJ, Bjørbaek C. Divergent regulation of proopiomelanocortin neurons by leptin in the nucleus of the solitary tract and in the arcuate hypothalamic nucleus. Diabetes. 2006;55: 567-573.
114. Bell CG, Walley AJ, Froguel P. The genetics of human obesity. Nat Rev Genet. 2005;6: 221-234.
115. Horvath TL, Diano S, Sotonyi P, Heiman M, Tschöp M. Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology. 2001;142: 4163-4169.
116. Meyer CW. Ultradian episodes of thermogenesis in mammals. In: Ruf T, Bieber C, Arnold W, Millesi E, ed. Living in Seasonal World Thremoregulatory and Metabolic Adaptations.NewYork: Springer; 2012;219-227.
117. Heldmaier G, Ortmann S, Elvert R. Natural hypometabolism during hibernation and daily torpor in mammals. Respir Physiol Neurobiol. 2004;141: 317-329.
118. Geiser F. Metabolic rate and body temperature reduction during hibernation and daily torpor. Annu Rev Physiol. 2004;66: 239-274.
119. Au-Yong IT, Thorn N, Ganatra R, Perkins AC, Symonds ME. Brown adipose tissue and seasonal variation in humans. Diabetes. 2009;58: 2583-2587.
120. Williams CT, Goropashnaya AV, Buck CL, et al. Hibernating above the permafrost: effects of ambient temperature and season on expression of metabolic genes in liver and brown adipose tissue of arctic ground squirrels. J Exp Biol. 2011;214: 1300-1306.
121. Ohkawa KI, Vogt MT, Farber E. Unusually high mitochondrial α glycerophosphate dehydrogenase activity in rat brown adipose tissue. J Cell Biol. 1969;41: 441-449.
122. Milner RE, Wang LC, Trayhurn P. Brown fat thermogenesis during hibernation and arousal in Richardson's ground squirrel. Am J Physiol. 1989;256:R42-R48.
123. Smalley RL, Dryer RL. Brown fat: thermogenic effect during arousal from hibernation in the bat. Science. 1963;140: 1333-1334.
124. Hayward JS, Ball EG. Quantitative aspects of brown adipose tissue thermogenesis during arousal from hibernation. Biol Bull. 1966; 131: 94-103.
125. Oelkrug R, Heldmaier G, Meyer CW. Torpor patterns, arousal rates, and temporal organization of torpor entry in wildtype and UCP1-ablated mice. J Comp Physiol B. 2011;181: 137-145.
126. Tamura Y MM, Odani M, Shiomi H. Involvement of the orexin system in thermoregulation of Syrian hamsters during arousal from hibernation. Neurosci Res. 2011;7: 72-73.
127. Hagan JJ, Leslie RA, Patel S, et al. Orexin A activates locus coeruleus cell firing and increases arousal in the rat. Proc Natl Acad Sci USA. 1999;96: 10911-10916.
128. González JA, Horjales-Araujo E, Fugger L, Broberger C, Burdakov D. Stimulation of orexin/hypocretin neurones by thyrotropin-releasing hormone. J Physiol. 2009;587: 1179-1186.
129. Hara J, Gerashchenko D, Wisor JP, Sakurai T, Xie X, Kilduff TS. Thyrotropin-releasing hormone increases behavioral arousal through modulation of hypocretin/orexin neurons. J Neurosci. 2009;29: 3705-3714.
130. Broberger C, McCormick DA. Excitatory effects of thyrotropinreleasing hormone in the thalamus. J Neurosci. 2005;25: 1664-1673.
131. Kitao N, Hashimoto M. Increased thermogenic capacity of brown adipose tissue under low temperature and its contribution to arousal from hibernation in Syrian hamsters. Am J Physiol Regul Integr Comp Physiol. 2012;302:R118-R125.
132. Herwig A, Ivanova EA, Lydon H, Barrett P, Steinlechner S, Loudon AS. Histamine H3 receptor and orexin A expression during daily torpor in the Djungarian hamster (Phodopus sungorus). J Neuroendocrinol. 2007;19: 1001-1007.
133. Schwartz C, Hampton M, Andrews MT. Seasonal and regional differences in gene expression in the brain of a hibernating mammal. PLoS One. 2013;8:e58427.
134. Dietrich H, Jenck F. Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant. Psychopharmacology (Berl). 2010;212: 145-154.
135. Steiner MA, Lecourt H, Jenck F. The brain orexin system and almorexant in fear-conditioned startle reactions in the rat. Psychopharmacology (Berl). 2012;223: 465-475.
136. Fronczek R, van Geest S, Frölich M, et al. Hypocretin (orexin) loss in Alzheimer's disease. Neurobiol Aging. 2012;33: 1642-1650.
137. Fronczek R, Overeem S, Lee SY, et al. Hypocretin (orexin) loss in Parkinson's disease. Brain. 2007;130: 1577-1585.
138. Degroot DW, Kenney WL. Impaired defense of core temperature in aged humans during mild cold stress. Am J Physiol Regul Integr Comp Physiol. 2007;292:R103-R108.
139. Brown SA, Schmitt K, Eckert A. Aging and circadian disruption: causes and effects. Aging (Albany NY). 2011;3: 813-817.
140. Roberts SB, Rosenberg I. Nutrition and aging: changes in the regulation of energy metabolism with aging. Physiol Rev. 2006;86: 651-667.
141. Svensson PA, JernåsM,Sjöholm K, et al. Gene expression inhuman brown adipose tissue. Int J Mol Med. 2011;27: 227-232.
142. Kozak LP, Koza RA, Anunciado-Koza R. Brown fat thermogenesis and body weight regulation in mice: relevance to humans. Int J Obes (Lond). 2010;34(suppl 1):S23-S27.
143. Bray GA, Greenway FL. Current and potential drugs for treatment of obesity. Endocr Rev. 1999;20: 805-875.
144. Fong TM. Advances in anti-obesity therapeutics. Expert Opin Investig Drugs. 2005;14: 243-250.